Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Effect of cannabidiol on sleep quality after late evening exercise
2024-518609-17-00Phase 2Authorised
- Sponsor
- UZ Leuven
- Start
- Jan 2026
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2 trial of cannabidiol in sleep disorder, sponsored by UZ Leuven. Primary endpoint: Sleep efficiency. Planned start Jan 2026; status: authorised.
02
Drugs
cannabidiol
03
Conditions
sleep disorder
Beyond the preview
Go deeper on 2024-518609-17-00.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2024-518609-17-00.